ImmunoPrecise Antibodies Files 6-K with Press Release
Ticker: HYFT · Form: 6-K · Filed: Jun 12, 2025 · CIK: 1715925
Sentiment: neutral
Topics: filing, press-release, sec
TL;DR
IPA filed a 6-K on June 12th, includes a press release - check for news.
AI Summary
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on June 12, 2025, reporting a press release dated June 12, 2025. The filing indicates the company is a foreign private issuer and will file annual reports under Form 20-F. The press release details are not included in this excerpt.
Why It Matters
This filing signals an update from ImmunoPrecise Antibodies Ltd. to the SEC, likely containing material information for investors.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that primarily serves to submit a press release, without immediate financial disclosures or significant corporate actions detailed in this excerpt.
Key Players & Entities
- ImmunoPrecise Antibodies Ltd. (company) — Registrant
- June 12, 2025 (date) — Filing and Press Release Date
- Jennifer Bath (person) — Signatory for the company
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report a press release dated June 12, 2025, from ImmunoPrecise Antibodies Ltd. to the SEC.
What is the filing date of this report?
This report was filed on June 12, 2025.
What is the Commission File Number for ImmunoPrecise Antibodies Ltd.?
The Commission File Number for ImmunoPrecise Antibodies Ltd. is 001-39530.
Does ImmunoPrecise Antibodies Ltd. file annual reports under Form 20-F or 40-F?
ImmunoPrecise Antibodies Ltd. indicates it files annual reports under Form 20-F.
Who signed this report on behalf of ImmunoPrecise Antibodies Ltd.?
Jennifer Bath signed this report on behalf of ImmunoPrecise Antibodies Ltd.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 12, 2025 by Jennifer Bath regarding ImmunoPrecise Antibodies Ltd. (HYFT).